Blinatumomab for Kids, Colonoscopy Timing, and GLP-1 Guardrails

Today we cover a major pediatric leukemia trial testing whether blinatumomab can replace toxic chemotherapy, new evidence on stretching colonoscopy surveillance from three to five years, and fresh expert guidance on prescribing weight loss drugs to people with eating disorders. We also look at how well cardiologists can eyeball frailty, an infection risk reality check for vasculitis treatments, and a new theoretical framework for Alzheimer's disease progression. A quick rundown covers five more notable studies in brain organoid models, lung cancer immunotherapy, obesity trends in China, and melanoma genetics.